Literature DB >> 8556507

Characterization of circulating CD4+ CD8+ lymphocytes in healthy individuals prompted by identification of a blood donor with a markedly elevated level of CD4+ CD8+ lymphocytes.

H E Prince1, J Golding, J York.   

Abstract

During flow cytometric analysis of lymphocytes from healthy donors, we identified a donor (donor A) with 22% CD4+ CD8+ cells (versus values of < 4% for 65 other controls). To determine if CD4+ CD8+ cells from donor A and other controls were similar, we first defined the phenotypic profile of control CD4+ CD8+ cells. Enriched CD4+ CD8+ cell populations for 10 controls were prepared by a two-step positive selection scheme with anti-CD4-coated magnetic beads and anti-CD8-coated culture flasks; the selected population averaged 69% CD4+ CD8+ cells and 31% CD4+ CD8- cells. For all 10 controls, two subsets of CD4+ CD8+ cells, CD4dim CD8bright and CD4bright CD8dim, were observed. Phenotypic profiles of these two CD4+ CD8+ subsets were defined by pairing anti-CD8 with other monoclonal antibodies, and the profiles were compared with each other and with those of CD4+ CD8-, CD4- CD8bright, and CD4- CD8dim cells. CD8bright and CD4bright CD8dim cells differed in their proportions of CD62-L+ cells and in their levels of CD11a and CD2 expression. Both CD4+ CD8+ subsets resembled CD4+ CD8- cells in CD45RA, CD45RO, and CD25 expression; the comparable CD- CD8+ cells in CD62-L expression; and CD4- CD8bright cells in CD11b, CD11b, CD16/56, and CD28 expression. CD38 expression in both CD4+ CD8+ subsets was decreased compared with those of other cell subsets. Whereas control CD4+ CD8+ cells averaged 33% CD4dim CD8bright, CD4+ CD8+ cells from donor A were > 90% CD4dim CD8bright. Donor A CD4dim CD8bright cells exhibited proportional decreases in CD25 and CD62-L expression and increases in CD11b and CD54 expression compared with those of control CD4dim CD8bright cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8556507      PMCID: PMC368347          DOI: 10.1128/cdli.1.5.597-605.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  21 in total

Review 1.  The indispensable CD2-CD3 molecules: a key to T-cell differentiation and functional activation.

Authors:  B Rubin; G Geisler; S Caspar; J Arnaud
Journal:  Scand J Immunol       Date:  1992-07       Impact factor: 3.487

2.  Increased CD4/CD8 coexpressed cells in a healthy subject.

Authors:  H Murakami; M Hayakawa; T Matsushima; M Sawamura; J Tamura; K Kubota
Journal:  J Leukoc Biol       Date:  1992-07       Impact factor: 4.962

3.  Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro.

Authors:  M L Blue; J F Daley; H Levine; K A Craig; S F Schlossman
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

Review 4.  The synergy between naive and memory T cells during activation.

Authors:  A N Akbar; M Salmon; G Janossy
Journal:  Immunol Today       Date:  1991-06

5.  Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells.

Authors:  A L Jackson; H Matsumoto; M Janszen; V Maino; A Blidy; S Shye
Journal:  Clin Immunol Immunopathol       Date:  1990-01

6.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

7.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.

Authors:  T A Waldmann
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

8.  The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.

Authors:  M L Baroja; K Lorre; F Van Vaeck; J L Ceuppens
Journal:  Cell Immunol       Date:  1989-04-15       Impact factor: 4.868

9.  Simultaneous determination of absolute total lymphocyte and CD4+ lymphocyte levels in peripheral blood by flow cytometry.

Authors:  H E Prince; W J Lesar
Journal:  Am J Clin Pathol       Date:  1989-08       Impact factor: 2.493

10.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

View more
  6 in total

1.  Significance of unconventional peripheral CD4+CD8dim T cell subsets.

Authors:  Claude Lambert; Lambert Claude; Mohammad Ibrahim; Ibrahim Mohammad; Cristina Iobagiu; Iobagiu Cristina; Christian Genin; Genin Christian
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

2.  Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes.

Authors:  Iole Macchia; Marie-Claire Gauduin; Amitinder Kaur; R Paul Johnson
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

3.  Aging related changes of circadian rhythmicity of cytotoxic lymphocyte subpopulations.

Authors:  Gianluigi Mazzoccoli; Angelo De Cata; Antonio Greco; Marcello Damato; Nunzia Marzulli; Mariangela Pia Dagostino; Stefano Carughi; Federico Perfetto; Roberto Tarquini
Journal:  J Circadian Rhythms       Date:  2010-05-25

4.  TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.

Authors:  Margarida Lima; Julia Almeida; Maria Dos Anjos Teixeira; Maria del Carmen Alguero Md; Ana Helena Santos; Ana Balanzategui; Maria Luís Queirós; Paloma Bárcena; Antonio Izarra; Sónia Fonseca; Clara Bueno; Benvindo Justiça; Marcos Gonzalez; Jesús F San Miguel; Alberto Orfao
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

5.  Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity.

Authors:  Seyed Mohammadreza Bolandi; Zohreh Abdolmaleki; Mohammad-Ali Assarehzadegan
Journal:  Inflammopharmacology       Date:  2021-03-19       Impact factor: 4.473

6.  Role of CD8-positive cells in radioimmunotherapy utilizing (177)Lu-mAbs in an immunocompetent rat colon carcinoma model.

Authors:  Erika Elgström; Sophie E Eriksson; Tomas G Ohlsson; Rune Nilsson; Jan Tennvall
Journal:  EJNMMI Res       Date:  2015-02-12       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.